Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ulrich Grädler

1PUBLICATIONS

11CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Feb 28, 2025

M4205 (IDRX-42) Is a Highly Selective and Potent Inhibitor of Relevant Oncogenic Driver and Resistance Variants of KIT in Cancer.

Christina Esdar, Nina Linde, Andreas Blum

Pageof 1

Frequent Collaborators

1 joint publications

Christina Esdar

1 joint publications

Nina LInde

1 joint publications

Andreas Blum

1 joint publications

Hanno Schieferstein

1 joint publications

Christine Drechsler

1 joint publications

Eva Sherbetjian

1 joint publications

Carl Petersson

1 joint publications

Edith Ross

1 joint publications

Birgitta Leuthner

1 joint publications

Dieter Dorsch

Frequent Collaborators

1 joint publications

Christina Esdar

1 joint publications

Nina LInde

1 joint publications

Andreas Blum

1 joint publications

Hanno Schieferstein

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos